Presentations

Documents

Order by : Name | Date | Hits | [ Ascendant ]

NAFLD: determining the optimal management path NAFLD: determining the optimal management path

hot!
Date added: 02/28/2018
Date modified: 02/28/2018
Filesize: 256 Bytes
Downloads: 1929

Invited oral presentation given by UHEL at the EASL International Liver Congress (ILC), Amsterdam, Netherlands, 19th - 23rd April 2017

Adipose tissue expandability, lipotoxicity and the metabolic syndrome Adipose tissue expandability, lipotoxicity and the metabolic syndrome

hot!
Date added: 11/25/2017
Date modified: 11/25/2017
Filesize: 256 Bytes
Downloads: 1928

Seminar given by UCAM at the MRC Clinical Sciences Centre, Imperial College London, UK, 11th January 2017

The European NAFLD registry The European NAFLD registry

hot!
Date added: 04/20/2018
Date modified: 04/20/2018
Filesize: 256 Bytes
Downloads: 1921

Oral presentation given by UNEW at the 1st International Conference on Fatty Liver (ICFL), Seville, Spain, 1st - 3rd June 2017

Effect of Dietary Intervention or Pioglitazone Therapy on Hepatic and Visceral Fat, Insulin... Effect of Dietary Intervention or Pioglitazone Therapy on Hepatic and Visceral Fat, Insulin...

hot!
Date added: 03/13/2018
Date modified: 03/13/2018
Filesize: 256 Bytes
Downloads: 1905

"Effect of Dietary Intervention or Pioglitazone Therapy on Hepatic and Visceral Fat, Insulin Resistance and Liver Histology in Patients with NASH"

Oral presentation given by CNR at the 5th EASD-NAFLD Study Group meeting, Gothenburg, Sweden, 8th - 9th May 2017

Natural history and genetic modifiers of NAFLD Natural history and genetic modifiers of NAFLD

hot!
Date added: 02/16/2018
Date modified: 02/16/2018
Filesize: 256 Bytes
Downloads: 1904

Oral presentation given by UNEW at the EASL International Liver Congress (ILC), Amsterdam, Netherlands, 19th - 23rd April 2017

Serum markers of fibrosis in NASH Serum markers of fibrosis in NASH

hot!
Date added: 03/10/2018
Date modified: 03/10/2018
Filesize: 256 Bytes
Downloads: 1887

Oral presentation given by UMC & NB at the EASL International Liver Congress (ILC), Amsterdam, Netherlands, 19th - 23rd April 2017

Why Should We Care About NAFLD? Why Should We Care About NAFLD?

hot!
Date added: 04/20/2018
Date modified: 04/20/2018
Filesize: 256 Bytes
Downloads: 1875

Oral presentation given by UNEW at the 1st International Conference on Fatty Liver (ICFL), Seville, Spain, 1st - 3rd June 2017

Heterogeneity of NAFLD in humans Heterogeneity of NAFLD in humans

hot!
Date added: 02/16/2018
Date modified: 02/16/2018
Filesize: 256 Bytes
Downloads: 1874

Invited oral presentation given by UHEL at the Symposium on NAFLD during The Endocrine Society Annual Meeting (ENDO 2017), Orlando, USA, 1st April 2017

NASH Therapeutics: Targets Under Evaluation in Early Phase Trials NASH Therapeutics: Targets Under Evaluation in Early Phase Trials

hot!
Date added: 04/20/2018
Date modified: 04/20/2018
Filesize: 256 Bytes
Downloads: 1841

Oral presentation given by UNEW at the 1st International Conference on Fatty Liver (ICFL), Seville, Spain, 1st - 3rd June 2017

NAFLD in a patient with the metabolic syndrome NAFLD in a patient with the metabolic syndrome

hot!
Date added: 02/28/2018
Date modified: 02/28/2018
Filesize: 256 Bytes
Downloads: 1834

Invited oral presentation given by UHEL at the EASL International Liver Congress (ILC), Amsterdam, Netherlands, 19th - 23rd April 2017